News und Analysen
2 Headwinds Facing Pfizer Stock Going Into 2026
The past few years have been a challenging ride for Pfizer (NYSE: PFE). Since the company made history in 2022, when it became the first in the biopharma industry to reach $100 billion in annual
1 Reason I'll Never Sell Vertex Pharmaceuticals Stock
Vertex Pharmaceuticals (NASDAQ: VRTX) has proven itself to be an excellent long-term investment, advancing 91% over the past five years. This is as the company has delivered steady growth in revenue
Could Buying AbbVie Today Set You Up for Life?
One effective way to earn solid, long-term returns is to invest in dividend-paying stocks since reinvesting the payout can help boost stock performance. However, they aren't all created equal, and
Prediction: 1 Healthcare Giant Set to Soar in 2026
Medtronic (NYSE: MDT), a medical device specialist, has lagged the market over the past five years. The company has experienced slow revenue growth, significant competition in some of its niches --
Why UnitedHealth Stock Popped on Wednesday
An analyst's price target increase for UnitedHealth Group (NYSE: UNH) stock was taken to heart by investors on Wednesday. Following news of the boost, they collectively pushed the large health insur
Up 37% Since August, Is It Safe to Buy UnitedHealth Group Stock Again?
For years, UnitedHealth Group (NYSE: UNH) has been one of the best growth stocks to own on the New York Stock Exchange. A leading health insurance company, it generated solid and continuous growth
UnitedHealth Stock Analysis: Buy or Sell?
UnitedHealth (NYSE: UNH) stock is testing the patience of investors.
*Stock prices used were the afternoon prices of Nov. 28, 2025. The video was published on Nov. 30, 2025.
Source
2 Top Dividend Stocks to Buy Now and Hold For a Decade
New investing trends pop up on Wall Street all the time. Over the past seven years, we have witnessed excitement surrounding cannabis stocks, the metaverse, artificial intelligence, and more
Is UnitedHealth an Undervalued Stock to Buy Now?
The U.S. healthcare industry has been a lightning rod for controversy for years, but it's especially murky right now.
A political battle continues within the U.S. government over renewing expired
2 Dividend Stocks to Double Up On Right Now
Earnings season always creates short-term winners and losers. Beverage behemoth Coca-Cola (NYSE: KO) and biotech giant Amgen (NASDAQ: AMGN) were firmly in the former category, as both delivered
2 Stocks to Buy Near Their 52-Week Lows
Recent developments have led to significant declines in the stock prices of Pinterest (NYSE: PINS) and Zoetis (NYSE: ZTS). Due to company-specific issues, both are currently not that far from their
Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been southbound over the past two years as the company navigates challenges to one of its main growth drivers, Eylea. This
2 Undervalued, High-Quality Companies to Buy Now and Hold Forever
Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY) are two of the largest and most respected pharmaceutical companies in the world. If you are looking to buy high-quality companies, they should
This Could Be the Most Compelling Value Play Before 2026's Economic Shift
Healthcare has been a painful industry to invest in this year. Rising claims usage and overall medical costs have sent expenses soaring for insurers such as UnitedHealth Group, whose stock is now
This 7% Yielder Could Be a Top AI Play
Shares of the pharmaceutical giant Pfizer (NYSE: PFE) have suffered over the last three years, falling some 50% since December 2022. Shares have been weighed down by the collapse in revenue from its
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio
While few investors have successfully timed the markets, buy-and-hold strategies tend to yield favorable results over the long term. The key is to select well-run companies that make highly
This Top Dividend King Just Became an Even Better Buy
Abbott Laboratories (NYSE: ABT), a medical device specialist, has a lot going its way. The company has a large and diversified portfolio of products, which it routinely expands through new launches
3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years
Want some quality income-generating investments you can put in your portfolio for the long term, and not worry about? The stocks listed below check off those boxes and can make for ideal investments
Forget CVS, Buy This Healthcare Stock Instead
CVS Health (NYSE: CVS) has been a huge outperformer this year. The stock is up about 79% so far in 2025 -- move than five times the return of the Health Care Select Sector SPDR Fund as well as the
Where Will Vertex Pharmaceuticals Be in 5 Years
A lot can change in five years. Take Vertex Pharmaceuticals (NASDAQ: VRTX), for example. In late 2020, the big biotech company's approved products focused on one indication – cystic fibrosis (CF)
Why Billionaire David Tepper Just Sold 92% of UnitedHealth Group and Is Buying These 3 Stocks Instead
Billionaire David Tepper's Appaloosa hedge fund has 45 holdings. That's large enough to be diversified. However, it's still small enough that it matters significantly which individual stocks and
Did Pfizer Just Say "Checkmate" to Novo Nordisk?
The words "Ozempic" and "Wegovy" almost have become household names as these products have changed the lives of many – from our own friends and family to celebrities. These drugs, prescribed for
Is This the Best Value Stock to Buy While Markets Are Volatile?
You may have noticed that the markets are exceptionally volatile at the moment. That's true whether we're talking about stocks, cryptocurrencies, or commodities.
During turbulent times, many
Should You Buy Shares of UnitedHealth in November?
This year hasn't been the easiest for UnitedHealth Group (NYSE: UNH). The biggest U.S. health insurer has faced several challenges, from the unexpected departure of its chief executive officer back
Why Centene Stock Just Popped
Health insurer Centene (NYSE: CNC) is helping lead the stock market higher this morning, rising 8% through 11:05 a.m. on positive healthcare news out of Washington, D.C.:
It looks like Obamacare


